Opinion

Video

Unmet Needs and Clinical Data with Hepatic Artery Infusion in Intrahepatic Cholangiocarcinoma

Author(s):

Ryan Merkow, MD, MSLouise Catherine Connell, MB BCh BAO, BMedSc

Drs Connell and Merkow discuss the current treatment landscape in intrahepatic cholangiocarcinoma and review recent clinical data in that space.

Related Videos
A panel of 3 experts on CLL
A panel of 3 experts on CLL
2 KOLs are featured in this program.
2 KOLs are featured in this program.
2 KOLs are featured in this series
2 KOLs are featured in this series
2 KOLs are featured in this series
3 KOLs are featured in this series.
3 KOLs are featured in this series.
Stephen J. Freedland, MD, and Eleni Efstathiou, MD, PhD, experts on prostate cancer
Related Content
Shubham Pant, MD, MBBS
July 24th 2024

Zanidatamab Demonstrates Activity in Pretreated HER2+ Biliary Tract Cancer

Nam Bui, MD, sarcoma specialist, clinical assistant professor, medicine, Stanford Cancer Institute; Ciara Kelly, MBBCh, BAO, interim clinical director, Sarcoma Oncology Service, Memorial Sloan Kettering Cancer Center
July 18th 2024

Bui and Kelly Discuss the Utility of Nab-Sirolimus in Advanced Malignant PEComa

RMC-6236 in Previously Treated PDAC
July 16th 2024

RMC-6236 Shows Activity With Favorable Toxicity Profile in Previously Treated PDAC

Ari Rosenberg, MD, assistant professor, medicine, University of Chicago Medicine
June 17th 2024

Rosenberg Reviews the Evolving Role of Toripalimab in Nasopharyngeal Carcinoma

Michael Patterson
July 10th 2024

FDA Approval Sought for Another Formulation of Lutetium Lu 177 Dotatate in SSTR+ GEP-NETs

Francesco Sclafani, MD, PhD, of Institut Jules Bordet
July 8th 2024

REGINA Data Support Further Evaluation of Neoadjuvant Regorafenib, Nivolumab, and SCRT in Rectal Cancer